Zim Laboratories Ltd

About [ edit ]

Zim Laboratories is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India.

  • Market Cap 140 Cr.
  • Current Price 86.4
  • High / Low 131 / 55.0
  • Stock P/E 14.7
  • Book Value 97.2
  • Dividend Yield 0.00 %
  • ROCE 5.39 %
  • ROE 2.17 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.89 times its book value

Cons

  • Promoter holding is low: 33.26%
  • Tax rate seems low
  • Company has a low return on equity of 8.01% for last 3 years.
  • Dividend payout has been low at 3.16% of profits over last 3 years
  • Company's cost of borrowing seems high
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
71.50 71.05 71.67 98.05 94.59 67.41 67.79 73.35 69.20 70.48 88.03 74.91
62.39 62.22 61.33 85.43 84.35 64.30 63.20 65.34 62.29 59.91 75.34 67.36
Operating Profit 9.11 8.83 10.34 12.62 10.24 3.11 4.59 8.01 6.91 10.57 12.69 7.55
OPM % 12.74% 12.43% 14.43% 12.87% 10.83% 4.61% 6.77% 10.92% 9.99% 15.00% 14.42% 10.08%
Other Income 7.44 0.34 0.19 0.72 0.80 1.05 0.42 0.61 2.43 0.62 -4.99 0.70
Interest 2.94 2.63 2.97 2.51 2.48 3.24 3.17 3.23 3.01 2.94 2.67 2.36
Depreciation 2.61 2.59 2.85 2.76 3.23 3.36 3.45 3.74 3.86 3.85 3.84 3.91
Profit before tax 11.00 3.95 4.71 8.07 5.33 -2.44 -1.61 1.65 2.47 4.40 1.19 1.98
Tax % 29.09% 4.05% 28.87% 27.01% 56.85% 103.28% 62.73% 7.27% 6.88% 25.23% 0.84% 34.85%
Net Profit 7.79 3.79 3.35 5.89 2.30 0.09 -0.61 1.52 2.30 3.28 1.19 1.29
EPS in Rs 2.35 2.08 3.65 1.43 0.06 -0.38 0.94 1.42 2.03 0.73 0.79

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
269 235 273 335 278 303
239 203 238 293 255 265
Operating Profit 30 32 35 42 23 38
OPM % 11% 13% 13% 13% 8% 12%
Other Income -2 5 9 2 5 -1
Interest 14 10 9 11 13 11
Depreciation 9 9 10 11 14 15
Profit before tax 5 18 25 22 0 10
Tax % 5% -6% 23% 30% -4,600%
Net Profit 5 19 19 15 3 8
EPS in Rs 9.52 2.04 4.97
Dividend Payout % 16% 4% 4% 5% 0%
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:6%
TTM:-0%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:-44%
TTM:190%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:42%
Return on Equity
10 Years:%
5 Years:%
3 Years:8%
Last Year:2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
8 8 8 16 16 16
Reserves 91 110 129 135 138 142
Borrowings 96 81 81 77 90 65
61 60 81 100 82 106
Total Liabilities 256 259 298 328 325 329
92 89 94 106 116 115
CWIP 3 4 8 13 10 5
Investments 0 0 0 0 0 0
161 166 196 209 200 209
Total Assets 256 259 298 328 325 329

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
22 32 37 35 22
-12 -7 -26 -21 -18
-10 -25 -10 -15 -3
Net Cash Flow -0 -0 1 -1 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 14% 14% 15% 5%
Debtor Days 120 137 119 101 89
Inventory Turnover 3.42 3.37 3.13 2.70

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
33.52 33.52 33.52 33.52 33.39 33.39 33.39 33.39 33.39 33.26 33.26 33.26
66.48 66.48 66.48 66.48 66.61 66.61 66.61 66.61 66.61 66.74 66.74 66.74

Documents